Hematology
Djordje Atanackovic, M.D.
Professor of Medicine, University of Maryland School of Medicine
Baltimore, MD
Dr. Atanackovic is a hematologist and immunotherapy researcher specializing in CAR T-cell therapy and blood cancers. He serves as Medical Director of the Fannie Angelos Cellular Therapeutics Laboratory and Director of Cellular and Vaccine Immunotherapy at the University of Maryland Greenebaum Comprehensive Cancer Center. His research focuses on novel immunotherapies including CAR T treatments for lymphomas and multiple myeloma.
25+
Years in Practice
Credentials
Education & Training
- MD, Freie University Berlin (1998)
- Residency, Internal Medicine, University Medical Center Hamburg-Eppendorf (2000)
- Fellowship, Oncology/Hematology, Ludwig Institute for Cancer Research (2003)
- Fellowship, Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf (2009)
Clinical Focus
Subspecialties
Multiple Myeloma
Conditions & Treatments
Multiple MyelomaCAR-T Cell Therapy
Practice Details
Hospital Affiliations
- University of Maryland Medical Center
Experience
25+ years in practice